CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
39.45
0.18%
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.12
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Baxter International Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 39.52
Open* 39.44
1-Year Change* -8.41%
Day's Range* 39.42 - 39.74
52 wk Range 31.01-50.21
Average Volume (10 days) 4.24M
Average Volume (3 months) 87.75M
Market Cap 19.70B
P/E Ratio 607.45
Shares Outstanding 507.32M
Revenue 14.82B
EPS 0.06
Dividend (Yield %) 2.98661
Beta 0.61
Next Earnings Date Feb 8, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 16, 2024 39.52 -0.32 -0.80% 39.84 39.95 39.29
Apr 15, 2024 39.98 -0.55 -1.36% 40.53 40.79 39.76
Apr 12, 2024 40.25 -1.37 -3.29% 41.62 41.75 40.15
Apr 11, 2024 42.05 -0.12 -0.28% 42.17 42.42 41.62
Apr 10, 2024 41.94 -0.08 -0.19% 42.02 42.15 41.20
Apr 9, 2024 42.77 0.67 1.59% 42.10 42.80 42.10
Apr 8, 2024 42.20 -0.20 -0.47% 42.40 42.54 42.04
Apr 5, 2024 42.56 0.59 1.41% 41.97 42.74 41.97
Apr 4, 2024 42.59 -0.67 -1.55% 43.26 43.61 42.27
Apr 3, 2024 43.24 0.61 1.43% 42.63 43.65 42.44
Apr 2, 2024 42.86 -0.09 -0.21% 42.95 43.25 42.57
Apr 1, 2024 43.49 0.19 0.44% 43.30 43.89 42.80
Mar 28, 2024 42.67 -0.02 -0.05% 42.69 43.03 42.37
Mar 27, 2024 42.64 1.11 2.67% 41.53 42.73 41.53
Mar 26, 2024 41.48 -0.12 -0.29% 41.60 41.87 41.18
Mar 25, 2024 41.72 -0.23 -0.55% 41.95 42.27 41.46
Mar 22, 2024 41.87 -0.01 -0.02% 41.88 42.12 41.53
Mar 21, 2024 41.88 0.09 0.22% 41.79 42.29 41.39
Mar 20, 2024 41.77 0.11 0.26% 41.66 42.09 41.57
Mar 19, 2024 41.88 0.64 1.55% 41.24 41.92 41.24

Baxter International Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

14:00

Country

US

Event

Baxter International Inc Annual Shareholders Meeting
Baxter International Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, May 2, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Baxter International Inc Earnings Call
Q1 2024 Baxter International Inc Earnings Call

Forecast

-

Previous

-

Time (UTC)

12:30

Country

US

Event

Q1 2024 Baxter International Inc Earnings Release
Q1 2024 Baxter International Inc Earnings Release

Forecast

-

Previous

-
Tuesday, May 7, 2024

Time (UTC)

14:00

Country

US

Event

Baxter International Inc Annual Shareholders Meeting
Baxter International Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, July 25, 2024

Time (UTC)

13:30

Country

US

Event

Q2 2024 Baxter International Inc Earnings Release
Q2 2024 Baxter International Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 15113 12784 11673 11362 11099
Revenue 15113 12784 11673 11362 11099
Cost of Revenue, Total 9690 7626 7038 6541 6305
Gross Profit 5423 5158 4635 4821 4794
Total Operating Expense 17207 11129 10213 10345 9492
Selling/General/Admin. Expenses, Total 3609 2619 2357 2397 2387
Research & Development 602 529 496 508 599
Unusual Expense (Income) 3306 355 322 899 210
Other Operating Expenses, Total -9
Operating Income -2094 1655 1460 1017 1607
Interest Income (Expense), Net Non-Operating -400 -170 -170 -124 -28
Other, Net 141 -8 2 77 38
Net Income Before Taxes -2353 1477 1292 970 1617
Net Income After Taxes -2421 1295 1110 817 1345
Net Income Before Extra. Items -2433 1284 1102 807 1345
Total Extraordinary Items 0 0 194 201
Net Income -2433 1284 1102 1001 1546
Income Available to Common Excl. Extra. Items -2433 1284 1102 807 1345
Income Available to Common Incl. Extra. Items -2433 1284 1102 1001 1546
Diluted Net Income -2433 1284 1102 1001 1546
Diluted Weighted Average Shares 504 508 517 519 546
Diluted EPS Excluding Extraordinary Items -4.82738 2.52756 2.13153 1.55491 2.46337
Dividends per Share - Common Stock Primary Issue 1.15 1.085 0.955 0.85 0.73
Diluted Normalized EPS 2.10317 3.0315 2.60928 2.84008 2.4359
Minority Interest -12 -11 -8 -10 0
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 3707 3513 3887 3773 3594
Revenue 3707 3513 3887 3773 3594
Cost of Revenue, Total 2330 2206 2418 2626 2219
Gross Profit 1377 1307 1469 1147 1375
Total Operating Expense 3747 3384 3696 6572 3319
Selling/General/Admin. Expenses, Total 823 766 986 782 811
Research & Development 165 157 153 148 148
Unusual Expense (Income) 377 203 139 2958 60
Operating Income -40 129 191 -2799 275
Interest Income (Expense), Net Non-Operating -157 -126 -153 -172 -66
Other, Net 14 11 186 5 10
Net Income Before Taxes -183 14 224 -2966 219
Net Income After Taxes -193 0 185 -2934 185
Minority Interest -2 -1 -4 -3 -3
Net Income Before Extra. Items -195 -1 181 -2937 182
Net Income -141 44 181 -2937 252
Income Available to Common Excl. Extra. Items -195 -1 181 -2937 182
Income Available to Common Incl. Extra. Items -141 44 181 -2937 252
Diluted Net Income -141 44 181 -2937 252
Diluted Weighted Average Shares 506 506 507 504 508
Diluted EPS Excluding Extraordinary Items -0.38538 -0.00198 0.357 -5.82738 0.35827
Dividends per Share - Common Stock Primary Issue 0.29 0.29 0.29 0.29 0.29
Diluted Normalized EPS 0.29051 0.31028 0.50296 0.43849 0.3937
Depreciation / Amortization 52 52 58 81
Total Extraordinary Items 54 45 70
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 8011 8872 8411 7503 5959
Cash and Short Term Investments 1718 2951 3730 3335 1838
Cash & Equivalents 1718 2951 3730 3335 1838
Short Term Investments
Total Receivables, Net 2752 2713 2077 1896 1840
Accounts Receivable - Trade, Net 2752 2713 2077 1896 1840
Total Inventory 2718 2453 1916 1653 1667
Prepaid Expenses 424 365 346 230 210
Other Current Assets, Total 399 390 342 389 404
Total Assets 28287 33521 20019 18193 15720
Property/Plant/Equipment, Total - Net 5529 5808 5325 5120 4530
Property/Plant/Equipment, Total - Gross 11971 12358 11874 11268 10333
Accumulated Depreciation, Total -6442 -6550 -6549 -6148 -5803
Goodwill, Net 6843 9836 3217 3030 3002
Intangibles, Net 6793 7792 1671 1471 1410
Other Long Term Assets, Total 653 835 1038 762 599
Total Current Liabilities 4745 4236 3333 3230 2814
Accounts Payable 1139 1246 1043 892 998
Payable/Accrued 571 638 704
Accrued Expenses 1801 2087 1053 961 900
Notes Payable/Short Term Debt 299 301 0 226 2
Current Port. of LT Debt/Capital Leases 1105 210 406 315 2
Other Current Liabilities, Total 401 392 260 198 208
Total Liabilities 22454 24444 11330 10311 7876
Total Long Term Debt 15232 17149 5786 4809 3481
Long Term Debt 15170 17081 5722 4755 3481
Deferred Income Tax 698 962 143 192 215
Minority Interest 62 44 37 30 22
Other Liabilities, Total 1717 2053 2031 2050 1344
Total Equity 5833 9077 8689 7882 7844
Common Stock 683 683 683 683 683
Additional Paid-In Capital 6322 6197 6043 5955 5898
Retained Earnings (Accumulated Deficit) 14050 17065 16328 15718 15075
Treasury Stock - Common -11389 -11488 -11051 -10764 -9989
Other Equity, Total -3833 -3380 -3314 -3710 -3823
Total Liabilities & Shareholders’ Equity 28287 33521 20019 18193 15720
Total Common Shares Outstanding 504.432 501.615 504.915 506.155 512.999
Note Receivable - Long Term 211 224 222 231 176
Long Term Investments 247 154 135 76 44
Capital Lease Obligations 62 68 64 54
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 12034 8205 8099 8011 7810
Cash and Short Term Investments 5788 1722 1673 1718 1601
Cash & Equivalents 5788 1722 1673 1718 1601
Total Receivables, Net 2553 2544 2639 2659 2555
Accounts Receivable - Trade, Net 2553 2544 2639 2659 2555
Total Inventory 2873 2897 2922 2718 2675
Prepaid Expenses 816 805 861 912 976
Other Current Assets, Total 4 237 4 4 3
Total Assets 30656 27885 28291 28287 27965
Property/Plant/Equipment, Total - Net 4797 5027 5554 5529 5345
Property/Plant/Equipment, Total - Gross 10863 11028 11622 11421 11084
Accumulated Depreciation, Total -6585 -6534 -6622 -6442 -6285
Goodwill, Net 6407 6418 6868 6843 6639
Intangibles, Net 6230 6470 6640 6793 6927
Other Long Term Assets, Total 1034 1621 1011 1111 1244
Total Current Liabilities 6209 5765 4760 4745 3708
Accounts Payable 1246 1240 1290 1139 1234
Accrued Expenses 2537 2120 2157 2202 2195
Notes Payable/Short Term Debt 514 249 50 299 275
Current Port. of LT Debt/Capital Leases 1912 1928 1103 1105 4
Total Liabilities 22555 22316 22412 22454 22430
Total Long Term Debt 14067 14306 15278 15232 16153
Long Term Debt 14067 14306 15278 15232 16153
Minority Interest 65 62 62 62 44
Other Liabilities, Total 2214 2183 2312 2415 2525
Total Equity 8101 5569 5879 5833 5535
Common Stock 683 683 683 683 683
Additional Paid-In Capital 6368 6341 6312 6322 6297
Retained Earnings (Accumulated Deficit) 16015 13655 13947 14050 14015
Treasury Stock - Common -11249 -11296 -11324 -11389 -11406
Other Equity, Total -3716 -3814 -3739 -3833 -4054
Total Liabilities & Shareholders’ Equity 30656 27885 28291 28287 27965
Total Common Shares Outstanding 507.296 506.37 505.836 504.432 504.044
Note Receivable - Long Term 154 144 119
Other Current Liabilities, Total 0 228 160
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -2421 1295 1110 1011 1546
Cash From Operating Activities 1211 2222 1868 2104 2017
Cash From Operating Activities 1403 890 823 789 771
Deferred Taxes -225 -146 -88 -310 -263
Non-Cash Items 3477 344 295 1039 211
Cash Taxes Paid 330 282 249 294 301
Cash Interest Paid 355 145 137 103 94
Changes in Working Capital -1023 -161 -272 -425 -248
Cash From Investing Activities -931 -11200 -1179 -1100 -916
Capital Expenditures -679 -743 -709 -696 -659
Other Investing Cash Flow Items, Total -252 -10457 -470 -404 -257
Cash From Financing Activities -1438 8245 -345 498 -2603
Financing Cash Flow Items -61 -138 -52 -48 -33
Total Cash Dividends Paid -573 -530 -473 -423 -376
Issuance (Retirement) of Stock, Net 95 -413 -298 -914 -2194
Issuance (Retirement) of Debt, Net -899 9326 478 1883 0
Foreign Exchange Effects -76 -47 57 -5 -63
Net Change in Cash -1234 -780 401 1497 -1565
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 45 -2421 -2606 328 73
Cash From Operating Activities 479 1211 772 482 208
Cash From Operating Activities 319 1403 1069 735 380
Deferred Taxes -50 -225 -174 -87 -55
Non-Cash Items 35 3477 3365 64 34
Changes in Working Capital 130 -1023 -882 -558 -224
Cash From Investing Activities -170 -931 -675 -491 -304
Capital Expenditures -172 -679 -479 -311 -140
Other Investing Cash Flow Items, Total 2 -252 -196 -180 -164
Cash From Financing Activities -372 -1438 -1319 -1017 -548
Financing Cash Flow Items -10 -61 -51 -30 -25
Total Cash Dividends Paid -146 -573 -427 -281 -140
Issuance (Retirement) of Stock, Net 36 95 82 88 66
Issuance (Retirement) of Debt, Net -252 -899 -923 -794 -449
Foreign Exchange Effects 18 -76 -130 -74 -13
Net Change in Cash -45 -1234 -1352 -1100 -657

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Baxter Company profile

About Baxter International Inc

Baxter International Inc. through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Baxter International Inc revenues increased 10% to $12.78B. Net income increased 17% to $1.28B. Revenues reflect Americas segment increase of 10% to $6.67B, APAC segment increase of 13% to $2.79B. Net income benefited from Americas segment income increase of 17% to $2.61B, APAC segment income increase of 5% to $623M. Dividend per share increased from $0.96 to $1.09.

Equity composition

Common Stock $1 Par, 03/11, 2B auth., 683,494,944 issd., Less 112,110,796 Shs. in Treas. @$6.1M. Insiders control approx. 0.15%. PO 6/86, 1.85M shares @$18.75 by Goldman Sachs. *FY'98-'01 are restated for disc. ops. 5/01, 2-for-1 stock split. *5/02, Co acquired Fusion Medical Technologies @ 0.1763 (2,507,881 shs. issd.).

Industry: Medical Equipment, Supplies & Distribution (NEC)

Df2-1W
One Baxter Pkwy
DEERFIELD
ILLINOIS 60015
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

ETH/USD

3,000.09 Price
-2.310% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,361.69 Price
-0.910% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.50 Price
-0.120% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

17,507.00 Price
-1.280% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading